Raise closed, search for fresh raises on Seedstage

Portsmouth, NH

Revolutionizing the injectable drug delivery market to enhance accessibility and ease of use for life-saving medications.

• Mission: Transforming the injectable drug delivery market by developing user-friendly, affordable auto-injectors that prioritize patient empowerment and accessibility for life-saving medications.  
• Innovation: Pirouette Medical’s QuicPush auto-injector simplifies the self-administration of medications like epinephrine and naloxone, addressing patient fears and enhancing ease of use.  
• Healthcare Impact: Aiming to improve the lives of millions affected by conditions such as anaphylaxis, Pirouette’s products empower patients to manage their own care with confidence.  
• Product Vision: Pirouette plans to expand its platform to accommodate a broad range of injectable drugs, enhancing its versatility in the medical market.  
• Leadership: Founded by engineers and healthcare innovators with expertise in aerospace and biomedical engineering, the company is positioned to drive significant advancements in medical device technology.  
• Strategic Positioning: Backed by a strong intellectual property portfolio and strategic partnerships, Pirouette is poised to make a meaningful impact in the $750 billion injectable drug market.  

Pirouette Medical is dedicated to transforming the landscape of injectable drug delivery by creating intuitive and affordable auto-injectors that prioritize user experience and accessibility. Founded by a team of engineers and healthcare innovators from prestigious institutions, the company aims to address significant barriers in the current injection market, which has remained stagnant for decades.

By focusing on user-friendly designs that eliminate the fear associated with needles, Pirouette seeks to empower patients to administer life-saving medications such as epinephrine and naloxone with ease. The company’s vision extends beyond these initial products, with plans to develop a versatile auto-injector platform applicable to a wide range of injectable drugs.

This initiative is supported by a robust intellectual property portfolio and strategic partnerships, positioning Pirouette for significant market penetration in the expansive $750 billion injectable drug market. The fundraising effort aims to engage the community in this mission, allowing individuals to invest in a future where life-saving treatments are accessible and manageable for all, ultimately striving to enhance healthcare outcomes for millions of patients in need.

Company Info

Pirouette Medical develops innovative medical devices to improve patient care, focusing on the treatment of anaphylaxis.

Pirouette Medical is a medical device company founded by three engineers with backgrounds in aerospace and biomedical engineering. The company aims to enhance patient care by developing innovative healthcare solutions, particularly focusing on the treatment of anaphylaxis. Their flagship product, QuicPush, is designed to make the administration of injections simpler and more accessible, allowing patients to self-administer medications with ease. Pirouette Medical emphasizes affordability, portability, and usability in its products, addressing the needs of over 50 million Americans affected by anaphylaxis due to various triggers. The company is committed to placing healthcare in the hands of patients and continuously seeks to innovate within the medical device industry. Their leadership team combines expertise in engineering, medical physics, and operations, and they are dedicated to improving the human condition through their advancements in medical technology.